SLC9A3 (Sodium/hydrogen exchanger 3) variants and mutations
SLC9A3 (also known as Sodium/hydrogen exchanger 3) is a human protein-coding gene encoding a sodium/hydrogen exchanger 3 protein. It exchanges luminal sodium for intracellular protons in intestinal and renal epithelia, supporting salt absorption and acid-base balance. Biallelic loss-of-function variants cause congenital sodium diarrhea with severe neonatal salt and fluid loss. This analysis covers 1,090 SLC9A3 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes congenital sodium diarrhea, hyperphosphatemia, and irritable bowel syndrome. Example SLC9A3 variants include M1V, W2*, and W2R.
Variant analysis overview
- Gene: SLC9A3
- Protein: Sodium/hydrogen exchanger 3
- UniProt accession: P48764
- Organism: Homo sapiens
- Variants analyzed: 1090
- Variant scope: all variants
- Completed: 2026-08-21
Variant and mutation evidence
- Variant composition: 954 unspecified-consequence records; 3 stop lost; 10 in-frame deletions; 15 synonymous variants; 58 missense variants; 35 frameshift variants; 5 stop-gained variants; 12 in-frame insertions; 2 substitution
- Prediction scores: 875 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: congenital sodium diarrhea, hyperphosphatemia, irritable bowel syndrome, neurodegenerative disease, Constipation, cystic fibrosis, chronic kidney disease, constipation disorder, autism spectrum disorder, alcohol drinking, age-related macular degeneration, Abdominal pain.
Protein structure and variant hotspots
- Protein features: 13 transmembrane segments; 7 binding sites; 9 post-translational modification sites.
- Structural context: 295 variants have structural context.
- PTM context: 13 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable SLC9A3 variants
Examples include M1V, W2*, W2R, G3E, A6D, A6F, A6P, A6S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1V (p.Met1Val), rs2126665147, ClinGen CA359018878, ClinVar RCV002015330, Uncertain significance, not provided
- W2* (p.Trp2Ter), gnomAD rs1357489625, CADD 34.00
- W2R (p.Trp2Arg), gnomAD rs1417204459, REVEL 0.06, CADD 14.70
- G3E (p.Gly3Glu), rs1333669177, ClinGen CA359018823, ClinVar RCV003118787, TOPMed rs1333669177, REVEL 0.04, CADD 14.20, Uncertain significance, not provided
- A6D (p.Ala6Asp), rs1579838227, ClinGen CA359018780, ClinVar RCV002711741, REVEL 0.02, CADD 7.18, Uncertain significance, not provided
- A6F (p.Ala6Phe), rs2477761307, ClinGen CA2580073107, ClinVar RCV002770295, Uncertain significance, not provided
- A6P (p.Ala6Pro), gnomAD rs1401436919, REVEL 0.06, CADD 8.15
- A6S (p.Ala6Ser), gnomAD rs1401436919, REVEL 0.04, CADD 2.26
- A6V (p.Ala6Val), Ensembl rs1579838227, REVEL 0.03, CADD 6.93
- R7Q (p.Arg7Gln), TOPMed rs1410804082, gnomAD rs1410804082, REVEL 0.01, CADD 5.48, Uncertain significance, Inborn genetic diseases
- G8D (p.Gly8Asp), rs978955926, ClinGen CA112819347, ClinVar RCV001942419, ClinVar RCV004039886, REVEL 0.15, CADD 16.20, Uncertain significance, not provided; Inborn genetic diseases
- G8S (p.Gly8Ser), gnomAD rs1413261532, REVEL 0.06, CADD 15.60
- P9L (p.Pro9Leu), Ensembl rs1452961775, REVEL 0.13, CADD 13.40
- D10N (p.Asp10Asn), TOPMed rs1165682837, gnomAD rs1165682837, REVEL 0.04, CADD 5.78
- D10Y (p.Asp10Tyr), TOPMed rs1165682837, gnomAD rs1165682837, REVEL 0.07, CADD 5.89
- R11P (p.Arg11Pro), 1000Genomes rs557874732, ExAC rs557874732, TOPMed rs557874732, gnomAD rs557874732, REVEL 0.08, CADD 14.80, Uncertain significance
- R11Q (p.Arg11Gln), rs557874732, ClinGen CA3176426, ClinVar RCV001898918, ClinVar RCV002555348, REVEL 0.12, CADD 13.00, Uncertain significance, not provided; Inborn genetic diseases
- R11W (p.Arg11Trp), TOPMed rs967916614, gnomAD rs967916614, REVEL 0.05, CADD 6.57, Uncertain significance, not provided
- G12E (p.Gly12Glu), 1000Genomes rs191409336, TOPMed rs191409336, gnomAD rs191409336, REVEL 0.03, CADD 7.50
- L14A (p.Leu14Ala), rs2126665055, ClinGen CA2573139551, ClinVar RCV002187351, Ensembl rs2126665055, Likely benign, not provided
- L14M (p.Leu14Met), 1000Genomes rs578220839, ExAC rs578220839, gnomAD rs578220839, REVEL 0.10, CADD 22.20, Uncertain significance, Inborn genetic diseases
- L14P (p.Leu14Pro), cosmic curated COSV53803, 1000Genomes rs556861051, ExAC rs556861051, gnomAD rs556861051, REVEL 0.20, CADD 23.60, Uncertain significance
- L14R (p.Leu14Arg), 1000Genomes rs556861051, ExAC rs556861051, gnomAD rs556861051, REVEL 0.12, CADD 22.20, Uncertain significance, Inborn genetic diseases
- L14V (p.Leu14Val), cosmic curated COSV53803, 1000Genomes rs578220839, ExAC rs578220839, gnomAD rs578220839, REVEL 0.07, CADD 21.50, Uncertain significance
- A18V (p.Ala18Val), TOPMed rs1733971657, REVEL 0.06, CADD 7.23
- L19R (p.Leu19Arg), Ensembl rs2126665025
- G20V (p.Gly20Val), TOPMed rs1733971293, gnomAD rs1733971293, REVEL 0.09, CADD 5.53, Uncertain significance, not provided
- G21A (p.Gly21Ala), gnomAD rs1733970964, REVEL 0.02, CADD 1.41
- G21V (p.Gly21Val), gnomAD rs1733970964, REVEL 0.03, CADD 5.16
- G21W (p.Gly21Trp), TOPMed rs1733971078, gnomAD rs1733971078, REVEL 0.07, CADD 21.30
- L22R (p.Leu22Arg), gnomAD rs1294352511, REVEL 0.12, CADD 17.10
- A23E (p.Ala23Glu), Ensembl rs1733970604, REVEL 0.06, CADD 4.24
- A23P (p.Ala23Pro), TOPMed rs1199285233
- R24L (p.Arg24Leu), rs1212776156, ClinGen CA359018596, ClinVar RCV002017621, ClinVar RCV004671613, REVEL 0.03, CADD 9.58, Uncertain significance, Inborn genetic diseases; not provided
- R24P (p.Arg24Pro), TOPMed rs1212776156, gnomAD rs1212776156, REVEL 0.07, CADD 11.10, Uncertain significance
- R24Q (p.Arg24Gln), rs1212776156, ClinGen CA359018595, ClinVar RCV001934027, TOPMed rs1212776156, REVEL 0.02, CADD 9.92, Uncertain significance, not provided
- A25V (p.Ala25Val), cosmic curated COSV10960, TOPMed rs1733970328, REVEL 0.07, CADD 8.95
- G26R (p.Gly26Arg), rs1560981486, Ensembl rs1560981486, REVEL 0.03, CADD 1.47, Variant assessed as somatic; moderate impact.
- G27D (p.Gly27Asp), rs774980944, ClinGen CA3176421, ClinVar RCV001919319, ClinVar RCV004671531, REVEL 0.04, CADD 6.25, Uncertain significance, not provided; Inborn genetic diseases
- E29D (p.Glu29Asp), rs2477760496, NCI-TCGA TCGA novel, ClinGen CA359018534, ClinVar RCV003016194, REVEL 0.05, CADD 8.89, Uncertain significance, not provided
- V30L (p.Val30Leu), TOPMed rs1007632649, REVEL 0.05, CADD 8.36
- P32H (p.Pro32His), gnomAD rs1425412486, REVEL 0.09, CADD 21.00
- P32S (p.Pro32Ser), rs1165460854, ClinGen CA359018490, ClinVar RCV004457029, TOPMed rs1165460854, REVEL 0.07, CADD 12.80, Uncertain significance, Inborn genetic diseases
- P32T (p.Pro32Thr), TOPMed rs1165460854, gnomAD rs1165460854, REVEL 0.08, CADD 11.20, Uncertain significance
- G33V (p.Gly33Val), gnomAD rs1180722289, REVEL 0.01, CADD 13.30
- G34C (p.Gly34Cys), TOPMed rs1249390870, gnomAD rs1249390870, REVEL 0.10, CADD 12.10
- G34S (p.Gly34Ser), TOPMed rs1249390870, gnomAD rs1249390870, REVEL 0.05, CADD 1.20
- G34V (p.Gly34Val), TOPMed rs1206413980, gnomAD rs1206413980, REVEL 0.02, CADD 1.60
- A35T (p.Ala35Thr), NCI-TCGA TCGA novel, TOPMed rs1733968558, REVEL 0.04, CADD 9.49, Variant assessed as somatic; moderate impact.
- A35V (p.Ala35Val), cosmic curated COSV10960, gnomAD rs1274127342, REVEL 0.04, CADD 11.80
- H36Y (p.His36Tyr), TOPMed rs1733968228, gnomAD rs1733968228, REVEL 0.07, CADD 16.00
- G37C (p.Gly37Cys), ExAC rs748423155, TOPMed rs748423155, gnomAD rs748423155, REVEL 0.06, CADD 20.50
- G37S (p.Gly37Ser), ExAC rs748423155, TOPMed rs748423155, gnomAD rs748423155, REVEL 0.03, CADD 9.59
- E38* (p.Glu38Ter), TOPMed rs1554001433, CADD 33.00
- E38D (p.Glu38Asp), rs1215714557, ClinGen CA359018385, ClinVar RCV001901785, TOPMed rs1215714557, REVEL 0.01, CADD 0.17, Uncertain significance, not provided
- S39G (p.Ser39Gly), TOPMed rs1733967641, REVEL 0.03, CADD 8.62
- S39N (p.Ser39Asn), rs772053823, ClinGen CA3176414, ClinVar RCV001365777, ClinVar RCV003169847, REVEL 0.03, CADD 0.41, Uncertain significance, Inborn genetic diseases; not provided
- G40R (p.Gly40Arg), cosmic curated COSV99376, TOPMed rs866241750, gnomAD rs866241750, REVEL 0.07, CADD 7.61
- G40W (p.Gly40Trp), TOPMed rs866241750, gnomAD rs866241750, REVEL 0.12, CADD 15.50, Uncertain significance, Inborn genetic diseases
- G41D (p.Gly41Asp), rs1372002924, ClinGen CA359018341, ClinVar RCV001956992, TOPMed rs1372002924, REVEL 0.15, CADD 21.20, Uncertain significance, not provided
- G41S (p.Gly41Ser), NCI-TCGA TCGA novel, REVEL 0.04, CADD 15.70, Variant assessed as somatic; moderate impact.
- G41V (p.Gly41Val), TOPMed rs1372002924, gnomAD rs1372002924, REVEL 0.16, CADD 22.90, Uncertain significance
- V44L (p.Val44Leu), Ensembl rs1733966918, REVEL 0.06, CADD 17.70
- V45I (p.Val45Ile), rs1733966738, ClinGen CA359018264, ClinVar RCV002030644, gnomAD rs1733966738, REVEL 0.13, CADD 23.30, Uncertain significance, not provided
- F47L (p.Phe47Leu), rs1733966635, ClinGen CA359018226, ClinVar RCV002939869, TOPMed rs1733966635, REVEL 0.08, CADD 19.60, Uncertain significance, Inborn genetic diseases
- E48* (p.Glu48Ter), TOPMed rs897639279, CADD 23.00
- E48K (p.Glu48Lys), TOPMed rs897639279, REVEL 0.12, CADD 0.01
- A50T (p.Ala50Thr), TOPMed rs1370824166, REVEL 0.07, CADD 11.90
- A50V (p.Ala50Val), TOPMed rs1474903418, REVEL 0.04, CADD 13.40
- H51Y (p.His51Tyr), gnomAD rs1348008469, REVEL 0.23, CADD 23.30
- V52M (p.Val52Met), NCI-TCGA TCGA novel, REVEL 0.47, CADD 25.70, Variant assessed as somatic; moderate impact.
- Q53H (p.Gln53His), rs868752117, Ensembl rs868752117, REVEL 0.40, CADD 23.40, Variant assessed as somatic; moderate impact.
- Y56* (p.Tyr56Ter), ExAC rs753413599, gnomAD rs753413599, CADD 37.00
- Y56C (p.Tyr56Cys), gnomAD rs1410511710, REVEL 0.62, CADD 28.10
- V57L (p.Val57Leu), Ensembl rs1733965616, REVEL 0.01, CADD 16.30
- A59E (p.Ala59Glu), Ensembl rs866782877, REVEL 0.38, CADD 25.10, Uncertain significance, Congenital secretory sodium diarrhea 8
- A59S (p.Ala59Ser), ExAC rs777362477, gnomAD rs777362477, REVEL 0.16, CADD 23.00
- A59T (p.Ala59Thr), NCI-TCGA Cosmic COSV9937, cosmic curated COSV99375, REVEL 0.17, CADD 23.40, Variant assessed as somatic; moderate impact.
- A59V (p.Ala59Val), NCI-TCGA TCGA novel, REVEL 0.16, CADD 22.70, Variant assessed as somatic; moderate impact.
- L67F (p.Leu67Phe), ExAC rs760008298, gnomAD rs760008298, REVEL 0.36, CADD 22.40
- I70M (p.Ile70Met), Ensembl rs1579837681, REVEL 0.27, CADD 22.80
- G71W (p.Gly71Trp), rs1560981289, ClinGen CA359017973, ClinVar RCV002022484, TOPMed rs1560981289, REVEL 0.21, CADD 32.00, Uncertain significance, not provided
- H73P (p.His73Pro), Ensembl rs1579794949, REVEL 0.58, CADD 27.60
- L74M (p.Leu74Met), NCI-TCGA TCGA novel, REVEL 0.28, CADD 22.70, Variant assessed as somatic; moderate impact.
- S75T (p.Ser75Thr), gnomAD rs1300266723, REVEL 0.11, CADD 23.30
- S75Y (p.Ser75Tyr), gnomAD rs1228802510, REVEL 0.24, CADD 26.50
- H76P (p.His76Pro), Ensembl rs1579794899
- H76Y (p.His76Tyr), TOPMed rs1739773374, REVEL 0.49, CADD 23.90, Uncertain significance, Inborn genetic diseases
- K77M (p.Lys77Met), TOPMed rs1035048787, REVEL 0.13, CADD 27.60
- V78A (p.Val78Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V78L (p.Val78Leu), TOPMed rs1390194882, gnomAD rs1390194882, REVEL 0.05, CADD 17.40
- T79N (p.Thr79Asn), rs2477626579, ClinGen CA359031652, ClinVar RCV003053566, Uncertain significance, not provided
- S80N (p.Ser80Asn), NCI-TCGA TCGA novel, REVEL 0.10, CADD 18.60, Variant assessed as somatic; moderate impact.
- S80R (p.Ser80Arg), rs969509137, ClinGen CA359031643, ClinVar RCV002039626, ClinVar RCV004671455, REVEL 0.05, CADD 3.57, Uncertain significance, Inborn genetic diseases; not provided
- V81L (p.Val81Leu), TOPMed rs1409190584, gnomAD rs1409190584, REVEL 0.03, CADD 12.20, Uncertain significance
- V81M (p.Val81Met), rs1409190584, ClinGen CA359031641, ClinVar RCV002806052, TOPMed rs1409190584, REVEL 0.16, CADD 17.50, Uncertain significance, not provided
- V82L (p.Val82Leu), rs1375511790, ClinGen CA359031634, ClinVar RCV001913938, TOPMed rs1375511790, REVEL 0.04, CADD 21.70, Uncertain significance, not provided
- E84K (p.Glu84Lys), ExAC rs751973348, TOPMed rs751973348, gnomAD rs751973348, REVEL 0.48, CADD 27.10
- A86S (p.Ala86Ser), 1000Genomes rs558720750, ExAC rs558720750, TOPMed rs558720750, gnomAD rs558720750, REVEL 0.12, CADD 23.70, Uncertain significance
- A86T (p.Ala86Thr), rs558720750, ClinGen CA3176383, ClinVar RCV003880785, ClinVar RCV004369673, REVEL 0.13, CADD 24.00, Uncertain significance, not provided; Inborn genetic diseases
- I89M (p.Ile89Met), ESP rs376704791, ExAC rs376704791, TOPMed rs376704791, gnomAD rs376704791, REVEL 0.32, CADD 21.40, Likely benign
- V90L (p.Val90Leu), 1000Genomes rs191669572, ESP rs191669572, ExAC rs191669572, TOPMed rs191669572, REVEL 0.06, CADD 16.10, Benign
- V90M (p.Val90Met), rs191669572, ClinGen CA3176380, cosmic curated COSV10960, ClinVar RCV002187617, REVEL 0.04, CADD 18.90, Benign, not provided
- V94L (p.Val94Leu), ExAC rs759214318, TOPMed rs759214318, gnomAD rs759214318, REVEL 0.11, CADD 16.70, Uncertain significance, Inborn genetic diseases
- V94M (p.Val94Met), ExAC rs759214318, TOPMed rs759214318, gnomAD rs759214318, REVEL 0.06, CADD 22.10
- G96D (p.Gly96Asp), NCI-TCGA Cosmic COSV9937, cosmic curated COSV99376, Variant assessed as somatic; moderate impact.
- G97S (p.Gly97Ser), rs1286293489, ClinGen CA359031550, ClinVar RCV003004985, TOPMed rs1286293489, REVEL 0.28, CADD 26.60, Uncertain significance, not provided
- V99I (p.Val99Ile), rs147688367, ClinGen CA3176375, cosmic curated COSV53801, ClinVar RCV003109000, REVEL 0.08, CADD 21.60, Uncertain significance, not provided
- A101V (p.Ala101Val), cosmic curated COSV53799, ESP rs368556738, ExAC rs368556738, TOPMed rs368556738, REVEL 0.15, CADD 24.50, Uncertain significance, Inborn genetic diseases
- A102G (p.Ala102Gly), TOPMed rs1400997657, gnomAD rs1400997657
- A102V (p.Ala102Val), NCI-TCGA TCGA novel, TOPMed rs1400997657, gnomAD rs1400997657, REVEL 0.24, CADD 24.20, Variant assessed as somatic; moderate impact.
- D103H (p.Asp103His), NCI-TCGA TCGA novel, REVEL 0.24, CADD 25.20, Variant assessed as somatic; moderate impact.
- D103N (p.Asp103Asn), rs747669825, ClinGen CA3176371, ClinVar RCV002597846, ClinVar RCV002612835, REVEL 0.13, CADD 22.40, Uncertain significance, Inborn genetic diseases; not provided
- H104N (p.His104Asn), gnomAD rs1739767938, REVEL 0.07, CADD 22.70
- H104R (p.His104Arg), gnomAD rs1158978167, REVEL 0.08, CADD 22.60
- I105T (p.Ile105Thr), TOPMed rs1739767304
- I105V (p.Ile105Val), ExAC rs746691223, gnomAD rs746691223, REVEL 0.04, CADD 12.70, Uncertain significance, Inborn genetic diseases
- A106T (p.Ala106Thr), rs1423288785, ClinGen CA359031491, ClinVar RCV002949245, TOPMed rs1423288785, REVEL 0.17, CADD 24.50, Uncertain significance, not provided
- A106V (p.Ala106Val), ESP rs371198920, ExAC rs371198920, TOPMed rs371198920, gnomAD rs371198920, REVEL 0.21, CADD 27.10
- S107P (p.Ser107Pro), Ensembl rs905241408
- T111M (p.Thr111Met), cosmic curated COSV10459, ExAC rs765856398, gnomAD rs765856398, REVEL 0.15, CADD 25.30
- T111S (p.Thr111Ser), rs2477626010, ClinGen CA359031460, ClinVar RCV003562425, ClinVar RCV004369283, Uncertain significance, Inborn genetic diseases; not provided
- P112L (p.Pro112Leu), Ensembl rs1739765929
- P112S (p.Pro112Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- T113N (p.Thr113Asn), Ensembl rs1739765738
- V114A (p.Val114Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V114I (p.Val114Ile), rs200473589, ClinGen CA3176360, NCI-TCGA Cosmic COSV5380, cosmic curated COSV53804, REVEL 0.05, CADD 14.50, Uncertain significance, Congenital secretory sodium diarrhea 8; Inborn genetic diseases; not provided
- F115V (p.Phe115Val), rs753749438, ClinGen CA3176359, ClinVar RCV002015063, ClinVar RCV002625364, REVEL 0.63, CADD 29.40, Uncertain significance, Inborn genetic diseases; not provided
- F116L (p.Phe116Leu), rs762737816, ExAC rs762737816, TOPMed rs762737816, gnomAD rs762737816, REVEL 0.23, CADD 28.00, Variant assessed as somatic; moderate impact.
- L120M (p.Leu120Met), Ensembl rs1739764319
- P121L (p.Pro121Leu), gnomAD rs1248713108, REVEL 0.50, CADD 24.70
- P122H (p.Pro122His), rs1406350252, gnomAD rs1406350252, REVEL 0.31, CADD 24.70, Variant assessed as somatic; moderate impact.
- I123S (p.Ile123Ser), NCI-TCGA Cosmic COSV5380, Variant assessed as somatic; high impact.
- V124L (p.Val124Leu), 1000Genomes rs566685003, ExAC rs566685003, TOPMed rs566685003, gnomAD rs566685003, Likely benign
- V124M (p.Val124Met), rs566685003, ClinGen CA3176353, ClinVar RCV001481604, ClinVar RCV003492254, REVEL 0.17, CADD 24.00, Likely benign, not provided; Congenital secretory sodium diarrhea 8
- D126E (p.Asp126Glu), rs768111524, ClinGen CA359031365, ClinVar RCV001910088, ExAC rs768111524, Uncertain significance, not provided
- A127T (p.Ala127Thr), rs1047334552, ClinGen CA112860009, ClinVar RCV001953136, UniProt VAR 076419, REVEL 0.17, CADD 22.60, Uncertain significance, not provided
- G128S (p.Gly128Ser), rs746669869, ClinGen CA3176351, ClinVar RCV002047862, ExAC rs746669869, REVEL 0.35, CADD 24.30, Uncertain significance, not provided
- Y129H (p.Tyr129His), TOPMed rs1739762707, REVEL 0.55, CADD 28.30
- M131R (p.Met131Arg), gnomAD rs1187650023, REVEL 0.56, CADD 27.60
- P132T (p.Pro132Thr), ExAC rs779578081, gnomAD rs779578081
- N133I (p.Asn133Ile), ExAC rs746260520, gnomAD rs746260520, REVEL 0.20, CADD 25.60
- N133T (p.Asn133Thr), ExAC rs746260520, gnomAD rs746260520, REVEL 0.13, CADD 25.10
- R134C (p.Arg134Cys), cosmic curated COSV53802, TOPMed rs1392517997, gnomAD rs1392517997, REVEL 0.24, CADD 28.50
- R134H (p.Arg134His), NCI-TCGA TCGA novel, TOPMed rs1274645242, gnomAD rs1274645242, REVEL 0.13, CADD 25.20, Variant assessed as somatic; moderate impact.
- R134L (p.Arg134Leu), TOPMed rs1274645242, gnomAD rs1274645242
- R134P (p.Arg134Pro), TOPMed rs1274645242, gnomAD rs1274645242, REVEL 0.20, CADD 25.70
- F136L (p.Phe136Leu), NCI-TCGA Cosmic COSV9937, cosmic curated COSV99376, Variant assessed as somatic; moderate impact.
- F137L (p.Phe137Leu), Ensembl rs919635437, REVEL 0.22, CADD 16.00
- G138A (p.Gly138Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- G138S (p.Gly138Ser), rs375884736, ClinGen CA3176344, ClinVar RCV001920383, ClinVar RCV005493151, REVEL 0.04, CADD 16.20, Uncertain significance, Inborn genetic diseases; not provided
- G141E (p.Gly141Glu), ExAC rs767647127, gnomAD rs767647127, REVEL 0.70, CADD 23.40
- G141R (p.Gly141Arg), NCI-TCGA Cosmic COSV9937, cosmic curated COSV99376, Variant assessed as somatic; moderate impact.
- I143M (p.Ile143Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L145S (p.Leu145Ser), TOPMed rs1386636117, gnomAD rs1386636117, REVEL 0.19, CADD 23.70
- Y146F (p.Tyr146Phe), gnomAD rs1371724563, REVEL 0.20, CADD 22.70
- A147V (p.Ala147Val), NCI-TCGA Cosmic COSV5380, cosmic curated COSV53801, REVEL 0.54, CADD 24.70, Variant assessed as somatic; moderate impact.
- V148I (p.Val148Ile), rs765054136, ClinGen CA3176338, cosmic curated COSV53800, ClinVar RCV001998482, REVEL 0.09, CADD 19.20, Uncertain significance, Inborn genetic diseases; not provided
- V149L (p.Val149Leu), ESP rs139970401, ExAC rs139970401, TOPMed rs139970401, gnomAD rs139970401, REVEL 0.04, CADD 2.06, Uncertain significance, Inborn genetic diseases
- V149M (p.Val149Met), rs139970401, ClinGen CA3176336, ClinVar RCV003564087, ClinVar RCV004723386, REVEL 0.08, CADD 9.77, Conflicting interpretations, Congenital secretory sodium diarrhea 8; not provided
- G150S (p.Gly150Ser), gnomAD rs1196489247, REVEL 0.54, CADD 24.60
- T151A (p.Thr151Ala), Ensembl rs1739758794
- T151I (p.Thr151Ile), Ensembl rs1579794368, REVEL 0.54, CADD 24.10
- V152A (p.Val152Ala), cosmic curated COSV53801, ESP rs142542253, ExAC rs142542253, TOPMed rs142542253, REVEL 0.09, CADD 21.40
- V152L (p.Val152Leu), rs760117543, ClinGen CA112859935, ClinVar RCV002717346, ExAC rs760117543, REVEL 0.11, CADD 9.54, Uncertain significance, not provided
- V152M (p.Val152Met), rs760117543, ClinGen CA3176334, ClinVar RCV001923632, ClinVar RCV003339825, REVEL 0.07, CADD 22.30, Uncertain significance, not provided; Inborn genetic diseases
- W153L (p.Trp153Leu), Ensembl rs2126630000
- A155T (p.Ala155Thr), rs755902342, ClinGen CA3176331, ClinVar RCV002666567, ClinVar RCV003269226, REVEL 0.10, CADD 17.90, Uncertain significance, not provided; Inborn genetic diseases
- A155V (p.Ala155Val), ESP rs376474403, ExAC rs376474403, TOPMed rs376474403, gnomAD rs376474403, REVEL 0.13, CADD 20.90, Uncertain significance, Inborn genetic diseases
- T157P (p.Thr157Pro), Ensembl rs1739757227
- T157S (p.Thr157Ser), TOPMed rs1369814708
- T158I (p.Thr158Ile), rs1739756990, ClinGen CA359031165, ClinVar RCV002686106, TOPMed rs1739756990, REVEL 0.11, CADD 15.40, Uncertain significance, not provided
- T158S (p.Thr158Ser), Ensembl rs2126629976
- G159A (p.Gly159Ala), TOPMed rs1360606745
- G159R (p.Gly159Arg), ExAC rs756156907, TOPMed rs756156907, gnomAD rs756156907, REVEL 0.57, CADD 24.10
- G164S (p.Gly164Ser), rs781351234, ClinGen CA3176324, ClinVar RCV002647121, ClinVar RCV003308211, REVEL 0.28, CADD 23.70, Uncertain significance, not provided; Inborn genetic diseases
- V165I (p.Val165Ile), rs369854335, ClinGen CA3176322, ClinVar RCV001940197, ESP rs369854335, REVEL 0.21, CADD 22.40, Uncertain significance, not provided
- L167F (p.Leu167Phe), TOPMed rs1045149774, REVEL 0.12, CADD 22.20
- L170F (p.Leu170Phe), ExAC rs761519337, gnomAD rs761519337, REVEL 0.08, CADD 15.80
- L170I (p.Leu170Ile), ExAC rs761519337, gnomAD rs761519337, REVEL 0.04, CADD 12.80
Public SLC9A3 analysis runs
- SLC9A3 analysis run — SLC9A3 (1,090 variants) — completed 2026-08-21